April 27, 2026 HCW Biologics Delivers a Major Update for its T-Cell Engager Program Revealing Mechanism of Action and Validating Tissue Factor as Target for Treatment of Solid Tumors
April 27, 2026 Medicus Pharma CEO meets with lawmakers on Energy & Commerce Committee on Capitol Hill
April 27, 2026 Vision Marine Technologies Secures Conditional TSX Venture Exchange Listing Approval, Expanding Capital Markets Access for Its Marine Technology Platform
April 27, 2026 ADC Therapeutics to Host First Quarter 2026 Financial Results Conference Call on May 4, 2026
